Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene, ENSG00000224012, is classified as a pseudogene similar to part of tropomyosin 2 (TPM2). Pseudogenes are nonfunctional DNA sequences that resemble protein-coding genes but typically lack the ability to express functional proteins. They arise through gene duplication or retrotransposition events and accumulate disabling mutations such as frameshifts or premature stop codons. As a result, this pseudogene does not encode a receptor, enzyme, or any other protein product, and is not considered a therapeutic target. The gene symbol "RP11-756G12.1" is sometimes used in genomic databases to refer to this locus[1][3][4]. Summary of suitability as a therapeutic target: ENSG00000224012 is not a functional protein-coding gene and should not be considered a therapeutic target or a biologically relevant entity for drug discovery or biomedical research applications[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of tropomyosin 2.